OXIGENE INC·4

Feb 28, 5:08 PM ET

LANGECKER PETER 4

4 · OXIGENE INC · Filed Feb 28, 2013

Insider Transaction Report

Form 4
Period: 2013-02-27
LANGECKER PETER
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-02-27+8,3338,333 total
    Exercise: $4.18Exp: 2023-02-27Common Stock (8,333 underlying)
Footnotes (1)
  • [F1]The Stock Option vests semi-annually in eight equal installments of 12.5% of the number of stock options granted beginning on August 27, 2013, six months following the grant date.

Documents

1 file
  • 4
    rrd372254.xmlPrimary